Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar protein sorting-associated protein 11 (VPS11) is a core component of both the CORVET and HOPS multisubunit tethering complexes, which are evolutionarily conserved and essential for vesicle fusion events in the endolysosomal system[1][2][3]. The class C core (VPS11 with VPS16, VPS18, and VPS33A) forms a structural backbone shared by both complexes, coordinating homotypic endosome fusion (via CORVET, involving Rab5) as well as late endosome-lysosome and autophagosome-lysosome fusion (via HOPS, involving Rab7)[1][2][3]. Functional deficiencies or mutations in VPS11 are associated with severe developmental and neurodegenerative diseases, including hypomyelination, leukoencephalopathy, and movement disorders[2][3]. In mammalian brain and other tissues, altered VPS11 expression and function can disrupt endolysosomal trafficking, myelin integrity, organelle assembly, and protein homeostasis[3][4]. No therapeutic drugs directly target VPS11, as its cellular role is structural/scaffold rather than as an enzyme, transporter, or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting-associated protein 11 (VPS11).